RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 14 analysts with an average price target of $256.18. This is a potential upside of $35.08 (15.87%) from yesterday's end of day stock price of $221.1.

ResMed's activity chart (see below) currently has 295 price targets and 277 ratings on display. The stock rating distribution of RMD is 37.14% HOLD and 62.86% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.5% with an average time for these price targets to be met of 198.82 days.

Highest price target for RMD is $321, Lowest price target is $215, average price target is $256.18.

Most recent stock forecast was given by CRAIG WONG-PAN from RBC on 15-Sep-2026. First documented stock forecast 27-Jun-2013.

Currently out of the existing stock ratings of RMD, 13 are a HOLD (37.14%), 22 are a BUY (62.86%).

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 07-Aug-2026

$262

$40 (18.02%)

$244

16 days ago
(15-Sep-2026)

25/32 (78.13%)

$32.56 (14.19%)

298

Buy Since 06-Feb-2024

$267

$45 (20.27%)

$255

1 months ago
(31-Aug-2026)

7/13 (53.85%)

$26.9 (11.20%)

144

Hold Since 19-Aug-2026

$230

$8 (3.60%)

1 months 12 days ago
(19-Aug-2026)

1/1 (100%)

$0.01 (0.00%)

2

Hold Since 13-Oct-2025

$215

$-7 (-3.15%)

$225

1 months 24 days ago
(07-Aug-2026)

4/5 (80%)

$3.67 (1.74%)

40

Hold Since 10-Jan-2025

$225

$3 (1.35%)

$275

1 months 24 days ago
(07-Aug-2026)

5/6 (83.33%)

$13.67 (6.47%)

51

Show more analysts

Please expand the browser size to see the chart

What is RMD (ResMed) average time for price targets to be met?

On average it took 199 days for the stock forecasts to be reached, with an average price target met ratio of 73.5%.

Which analyst most recently updated their price target on RMD (ResMed)?

Craig Wong-Pan

Which analyst has the most public recommendations on RMD (ResMed)?

Craig Wong-Pan works at RBC and has 56 price targets and 37 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Craig Wong-Pan with the highest potential upside of $120.71

Which analyst is the currently most reserved on RMD (ResMed)?

Andrew Paine with the lowest potential downside of -$197.87
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?